SCHEMBL24207063

SCHEMBL24207063

COc1cc(N2CCN(C3CNC3)CC2)ccc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.67
▸ ALK Q9UM73 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22027940 0.90 EGFR (0.81) EGFRALK
SCHEMBL24207268 0.90 EGFR (0.83) EGFR
SCHEMBL25370512 0.87 EGFR (0.78) EGFR
SCHEMBL29257993 0.86 EGFR (0.67) EGFR
SCHEMBL29877372 0.84 EGFR (0.69) EGFR
SCHEMBL29257807 0.84 EGFR (0.69) EGFR
SCHEMBL23420378 0.83 EGFR (0.56) EGFR
SCHEMBL24207420 0.82 EGFR (0.59) EGFR
SCHEMBL22028077 0.82 EGFR (0.76) EGFRALK
SCHEMBL25144549 0.82 EGFR (0.69) EGFRALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022012622-A1 DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2022-01-20 — — WO disclosed
Send feedback